Skip to main content

Table 3 Evolution of the monthly average cost of antiasthmatic drugs compared to guaranteed minimum wage moroccan asthma

From: Trends in the use of antiasthmatic medications in Morocco (1999–2010)

 

1999

2006

2010

AME

AME/GMW

NS

NP

AME

AME/GMW

NS

NP

AME

AME/GMW

NS

NP

Short-acting inhaled Beta-2-mimetic

66.5

4.01

7

9

77.5

3.86

9

11

38.61

1.83

8

12

Long-acting inhaled Beta-2-mimetic

425.5

25.64

2

3

265.04

13.19

3

4

209.17

9.92

2

2

Systemic Beta-2-mimetic

76.4

4.60

4

14

68.61

3.41

7

18

71.27

3.38

6

13

Inhaled Glucocorticosteroids alone

192.9

11.82

5

9

147.06

7.32

8

15

144.66

6.86

11

15

Association Beta-2-mimetic /Glucocorticosteroids

-

-

-

-

363.02

18.07

2

6

209.20

9.92

4

13

Injectable Xanthines

46.1

2.77

9

22

54.73

2.72

9

18

56.07

2.67

5

13

 

(161.40 ± 158.32)

(9.77 ± 9.55)

27

57

(162.66 ± 125.39)

(8.10 ± 6,24)

38

72

(121.5 ± 76.93)

(5.76 ± 3.65)

36

68

  1. AME : Average Monthly Expenditure (MAD).
  2. GMW : Guaranteed Minimum Wage (MAD) (High Commission of Planning-HCP 2010).
  3. AME/GMW : In percentage.
  4. NS : Number of Specialties / NP : Number of Pharmaceutical Presentations.
  5. 1999 : GMW = 150.89 € AME/GMW = 9.72% CI = [2.12% ; 21.56%] with 95%.
  6. 2006 : GMW = 182.66 € AME/GMW = 8.10% CI = [1.54% ; 14.65%] with 95%.
  7. 2010 : GMW = 191.74 € AME/GMW = 5.76% CI = [1.94% ; 9.59%] with 95%.